ResMed outlines 62%-63% gross margin target for fiscal 2026 amid double-digit growth in key segments
Source: SeekingAlpha
2026-01-29 20:24:13 ET
More on ResMed
- ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript
- 44th Annual J.P. Morgan Healthcare Conference
- ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ResMed Q2 2026 Earnings Preview
- Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026
Read the full article on Seeking Alpha
For further details see:
ResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments
Resmed Inc. Chess Depository Interest
NASDAQ: RSMDF
RSMDF Trading
0.0% G/L:
$25.67 Last:
507 Volume:
$25.67 Open:
RSMDF Latest News
RSMDF Stock Data
$40,201,411,540
146,930,660
N/A
121
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
